Welcome to the genitourinary (GU) cancer channel. Explore the latest updates in GU cancer, including expert interviews from major international congresses and news by subtype.

Genitourinary cancer is any cancer of the genitourinary system, including the bladder, prostate, kidneys, testicles, penis, ureter and adrenal glands. The treatment of these cancers are managed by urologists and/or oncologists, depending upon the type of treatment. Minimally-invasive techniques, as well as traditional chemoradiotherapy are utilized.

Exciting advances are being made in the field of genitourinary cancer, including checkpoint inhibitor treatments, new non-steroidal anti-androgens, chemoimmunotherapy combinations and predictive biomarkers.

Genitourinary Cancer

The Genitourinary Cancer Channel on VJOncology is supported by a grant from Pfizer Inc and Merck KGaA.

The supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Genitourinary Cancer Channel, please contact us

Genitourinary Cancer

Welcome to the genitourinary (GU) cancer channel. Explore the latest updates in GU cancer, including expert interviews from major international congresses and news by subtype.

Genitourinary cancer is any cancer of the genitourinary system, including the bladder, prostate, kidneys, testicles, penis, ureter and adrenal glands. The treatment of these cancers are managed by urologists and/or oncologists, depending upon the type of treatment. Minimally-invasive techniques, as well as traditional chemoradiotherapy are utilized.

Exciting advances are being made in the field of genitourinary cancer, including checkpoint inhibitor treatments, new non-steroidal anti-androgens, chemoimmunotherapy combinations and predictive biomarkers.

View all videos
The Genitourinary Cancer Channel on VJOncology is supported by a grant from Pfizer Inc and Merck KGaA.

The supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Genitourinary Cancer Channel, please contact us

Latest videos VJSessions Subtypes Topics Conferences Features Editorial Board

GU Cancer Videos by Subtype

Prostate Cancer
Bladder Cancer
Kidney Cancer
Testicular Cancer
Penile Cancer
3:45
Impacts of COVID-19 infection on patients with urological cancers undergoing surgery
Chuanyu Gao • 7 Jul 2021
3:59
EMT switch activation by peri-neural invading epithelial cells decreases OS in prostate cancer
Noel Clarke • 16 Jul 2021
5:31
Updates on the systemic treatment of metastatic HSPC
Noel Clarke • 16 Jul 2021
1:19
NOV202 increases olaparib efficacy in prostate cancer xenografts
Evangelia Sereti • 12 Jul 2021
View All Videos
3:45
Impacts of COVID-19 infection on patients with urological cancers undergoing surgery
Chuanyu Gao • 7 Jul 2021
3:04
Benefits of T1 substaging for NMIBC
Christiaan De Jong • 21 Jul 2021
4:19
Novel biomarkers for outcomes identified in BCG-treated T1HG bladder cancer
Christiaan De Jong • 21 Jul 2021
3:27
Improving anti-PD-1/PD-L1 therapy for localized bladder cancer
Christiaan De Jong • 21 Jul 2021
View All Videos
3:45
Impacts of COVID-19 infection on patients with urological cancers undergoing surgery
Chuanyu Gao • 7 Jul 2021
2:29
Association between severe irAEs and PDCD1 polymorphism in mRCC
Kazuyuki Numakura • 29 Jun 2021
2:38
Real-world analysis of AEs associated with alpha blockers and drugs for mRCC
Cosimo De Nunzio • 1 Jul 2021
5:26
DFIR CAR T-cell therapy for clear cell RCC
Yufei Wang • 15 Apr 2021
View All Videos
7:05
TRISST: MRI versus FDG-PET-CT for the treatment of testicular cancer
Tahlita Zuiverloon • 15 Jul 2021
3:40
Surgery in metastatic germ cell tumors to reduce disease burden and improve long-term outcomes
Peter Albers • 8 Jul 2021
3:34
Benefits of circulating miRNAs for follow-up of patients with seminoma
Matthew Murray • 1 Jul 2021
1:12
miR-371a-3p microRNA panel alone is sufficient for diagnosis and monitoring
Matthew Murray • 1 Jul 2021
View All Videos
5:44
Long-term outcomes of DSNB for cN0 penile cancer
Edoardo Pozzi • 10 Jul 2021
2:06
c-MET receptor-targeted fluorescence for image-guided surgery in PSCC
Hielke-Martijn De Vries • 7 Jul 2021
3:14
Factors impacting additional tumour-bearing lymph nodes at completion ILND after positive DSNB
Hielke-Martijn De Vries • 7 Jul 2021
1:28
Risk factor analysis of complications after sentinel node biopsy for penile cancer
Hielke-Martijn De Vries • 7 Jul 2021
View All Videos

Topics

Trial Updates
Molecular Profiling
Immuno-Oncology
Diagnosis
Imaging
3:45
Impacts of COVID-19 infection on patients with urological cancers undergoing surgery
Chuanyu Gao • 7 Jul 2021
2:31
Key immunotherapy combinations for urothelial cancer
Matthew Galsky • 12 Jul 2021
7:05
TRISST: MRI versus FDG-PET-CT for the treatment of testicular cancer
Tahlita Zuiverloon • 15 Jul 2021
5:31
Updates on the systemic treatment of metastatic HSPC
Noel Clarke • 16 Jul 2021
View All Videos
3:04
Benefits of T1 substaging for NMIBC
Christiaan De Jong • 21 Jul 2021
4:19
Novel biomarkers for outcomes identified in BCG-treated T1HG bladder cancer
Christiaan De Jong • 21 Jul 2021
2:29
Association between severe irAEs and PDCD1 polymorphism in mRCC
Kazuyuki Numakura • 29 Jun 2021
3:34
Benefits of circulating miRNAs for follow-up of patients with seminoma
Matthew Murray • 1 Jul 2021
View All Videos
3:27
Improving anti-PD-1/PD-L1 therapy for localized bladder cancer
Christiaan De Jong • 21 Jul 2021
2:31
Key immunotherapy combinations for urothelial cancer
Matthew Galsky • 12 Jul 2021
1:35
CheckMate 274: adjuvant nivolumab versus placebo for urothelial carcinoma
Matthew Galsky • 12 Jul 2021
4:45
PrE0807: neoadjuvant nivolumab/lirilumab in cisplatin ineligible patients with MIBC
Petros Grivas • 11 Jun 2021
View All Videos
1:12
miR-371a-3p microRNA panel alone is sufficient for diagnosis and monitoring
Matthew Murray • 1 Jul 2021
5:32
CADMUS trial: multiparametric ultrasound in prostate cancer diagnosis
Alistair Grey • 1 Jun 2021
3:01
Future research in multiparametric imaging for prostate cancer diagnosis
Alistair Grey • 1 Jun 2021
1:37
Improving the stratification of prostate cancer
Alistair Grey • 1 Jun 2021
View All Videos
7:05
TRISST: MRI versus FDG-PET-CT for the treatment of testicular cancer
Tahlita Zuiverloon • 15 Jul 2021
4:42
PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients with prostate cancer
Frederic Pouliot • 4 Jun 2021
3:14
Novel MRI approach for prostate cancer screening
Peter Albers • 8 Jul 2021
3:20
Radiation therapy for the local treatment of metastatic hormone-sensitive prostate cancer
Piet Ost • 2 Jul 2021
View All Videos

Conferences

EAU 2021
ASCO 2021
AACR 2021
GU Cancers 2021
PROSCA/BLADDR 2020
ESMO 2020
3:45
Impacts of COVID-19 infection on patients with urological cancers undergoing surgery
Chuanyu Gao • 7 Jul 2021
3:04
Benefits of T1 substaging for NMIBC
Christiaan De Jong • 21 Jul 2021
4:19
Novel biomarkers for outcomes identified in BCG-treated T1HG bladder cancer
Christiaan De Jong • 21 Jul 2021
3:27
Improving anti-PD-1/PD-L1 therapy for localized bladder cancer
Christiaan De Jong • 21 Jul 2021
View All Videos
4:42
PSMA-targeted imaging with 18F-DCFPyL-PET/CT in patients with prostate cancer
Frederic Pouliot • 4 Jun 2021
4:45
PrE0807: neoadjuvant nivolumab/lirilumab in cisplatin ineligible patients with MIBC
Petros Grivas • 11 Jun 2021
5:49
JAVELIN Bladder 100 trial updates from ASCO 2021
Petros Grivas • 11 Jun 2021
10:12
Trial updates in prostate cancer from ASCO 2021: VISION, PEACE1, & SWOG S1216
Pedro Barata • 8 Jun 2021
View All Videos
3:07
PSMA dRT: PSMA PET/CT before radiotherapy in prostate cancer
Jeremie Calais • 22 Apr 2021
6:49
RAMP: Phase Ib study of rucaparib & enzalutamide in mCRPC
Arpit Rao • 19 Apr 2021
4:38
Clinical utility of liquid biopsies in prostate cancer
Arpit Rao • 19 Apr 2021
3:53
Upcoming advances in prostate cancer: PARPi, CDK4/6, lutetium PSMA therapy & CAR-T approaches
Arpit Rao • 19 Apr 2021
View All Videos
1:50
Current treatment landscape of seminoma
Siamak Daneshmand • 18 Feb 2021
3:05
CA 125, CA19-9 and CEA: tumor markers in bladder cancer
Siamak Daneshmand • 18 Feb 2021
3:18
SEMS: surgery as first-line therapy for seminoma
Siamak Daneshmand • 18 Feb 2021
3:43
The history of biomarkers in the treatment of prostate cancer
Howard Scher • 18 Feb 2021
View All Videos
0:53
Immunotherapy in prostate cancer
Emmanuel Seront • 7 Oct 2020
1:29
Genomic testing in prostate cancer
Emmanuel Seront • 7 Oct 2020
0:38
Second-line treatment of mHSPC
Ursula Vogl • 7 Oct 2020
1:35
Unmet needs in mHSPC
Ursula Vogl • 7 Oct 2020
View All Videos
6:14
ESMO highlights: 705MO study in GU cancer
Pavlos Msaouel • 19 Sep 2020
3:11
PRS-343 in HER2-Positive Solid Tumors: A trial update
Geoffrey Ku • 24 Sep 2020
3:53
Sacituzumab govitecan in metastatic urothelial carcinoma: updates on the Phase II study
Yohann Loriot • 23 Sep 2020
3:20
Updates on the DANUBE, KEYNOTE-361 and JAVELIN Studies
Yohann Loriot • 23 Sep 2020
View All Videos

The GU Channel on VJOncology is supported by a grant from Pfizer Inc and Merck KGaA. The supporters have no influence over the production of the content.

If you are interested in becoming a supporter of The Genitourinary (GU) Cancer Channel, please contact us

VJOncology VJOncology is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJOncology is intended for healthcare professionals